TRPV1 and breast cancer: It has been reported that TRPV1 activation via capsaicin together with MRS1477 largely reduces MCF-7 viability (41), which is not observed in primary breast epithelial cells, indicating TRPV1 is a potential drug target for treating breast cancers without affecting normal cells.